301 related articles for article (PubMed ID: 26951615)
1. Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy.
Riley TR; Gauthier-Lewis ML; Sanchez CK; Riley TT
J Pharm Pract; 2017 Apr; 30(2):214-218. PubMed ID: 26951615
[TBL] [Abstract][Full Text] [Related]
2. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
Berry NC; Mauri L; Steg PG; Bhatt DL; Hohnloser SH; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Ten Berg JM; Cannon CP
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008349. PubMed ID: 32252548
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
4. Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
Flack KF; Desai J; Kolb JM; Chatterjee P; Wallentin LC; Ezekowitz M; Yusuf S; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
Clin Gastroenterol Hepatol; 2017 May; 15(5):682-690. PubMed ID: 27765728
[TBL] [Abstract][Full Text] [Related]
5. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experience.
Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Spurr C; Sridhar S
Korean J Gastroenterol; 2015 Apr; 65(4):205-14. PubMed ID: 25896154
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
Romanelli RJ; Nolting L; Dolginsky M; Kym E; Orrico KB
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):126-34. PubMed ID: 26812933
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
Chan YH; Yen KC; See LC; Chang SH; Wu LS; Lee HF; Tu HT; Yeh YH; Kuo CT
Stroke; 2016 Feb; 47(2):441-9. PubMed ID: 26732563
[TBL] [Abstract][Full Text] [Related]
9. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Cannon CP; Bhatt DL; Oldgren J; Lip GYH; Ellis SG; Kimura T; Maeng M; Merkely B; Zeymer U; Gropper S; Nordaby M; Kleine E; Harper R; Manassie J; Januzzi JL; Ten Berg JM; Steg PG; Hohnloser SH;
N Engl J Med; 2017 Oct; 377(16):1513-1524. PubMed ID: 28844193
[TBL] [Abstract][Full Text] [Related]
10. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
Sam C; Massaro JM; D'Agostino RB; Levy D; Lambert JW; Wolf PA; Benjamin EJ;
Am J Cardiol; 2004 Oct; 94(7):947-51. PubMed ID: 15464686
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
12. Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study.
Ellis MH; Neuman T; Bitterman H; Dotan SG; Hammerman A; Battat E; Eikelboom JW; Ginsberg JS; Hirsh J
Eur J Intern Med; 2016 Sep; 33():55-9. PubMed ID: 27296588
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
14. Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis.
Jiang H; Jiang Y; Ma H; Zeng H; Lv J
Clin Cardiol; 2021 Sep; 44(9):1208-1215. PubMed ID: 34302375
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
[TBL] [Abstract][Full Text] [Related]
16. Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.
Lau WCY; Li X; Wong ICK; Man KKC; Lip GYH; Leung WK; Siu CW; Chan EW
J Thromb Haemost; 2017 Oct; 15(10):1923-1933. PubMed ID: 28748652
[TBL] [Abstract][Full Text] [Related]
17. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
Abe J; Umetsu R; Kato Y; Ueda N; Nakayama Y; Suzuki Y; Suzuki T; Nagasawa H; Kinosada Y; Nakamura M
Int J Med Sci; 2015; 12(4):312-21. PubMed ID: 25897292
[TBL] [Abstract][Full Text] [Related]
19. Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
Kolb JM; Flack KF; Chatterjee-Murphy P; Desai J; Wallentin LC; Ezekowitz M; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
Dig Dis Sci; 2018 Jul; 63(7):1878-1889. PubMed ID: 29582237
[TBL] [Abstract][Full Text] [Related]
20. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
